Alleviating the Financial Burden for Dialysis Patients in Low-and Middle-Income Countries During the COVID-19 Pandemic

2020 ◽  
Vol In Press (In Press) ◽  
Author(s):  
Md Sohrab Hosen ◽  
Md Nafiujjaman ◽  
Tawhida Rahman Nishat
Keyword(s):  
Financial Burden ◽  
Dialysis Patients ◽  
Middle Income ◽  
Middle Income Countries ◽  
Low And Middle Income

scholarly journals The Global Burden of Surgical Disease: An Analysis on Inaccessible Surgical Care in Low and Middle Income Countries

2018 ◽  
Vol 7 (1) ◽  
pp. 8-15 ◽  
Author(s):  
Chau Huynh ◽  
Minh NQ Huynh
Keyword(s):  
Global Health ◽  
Financial Burden ◽  
Surgical Care ◽  
Anaesthetic Management ◽  
Global Burden ◽  
Political Climate ◽  
Middle Income ◽  
Surgical Interventions ◽  
Middle Income Countries ◽  
Low And Middle Income

Worldwide, 4.8 billion people do not have access to safe, adequate surgical care and anaesthetic management. Surgical care has been deemed “the neglected child of global health,” a startling reminder of the disparities in health services. The provision of surgical interventions can avert 11% of the global burden of disease and 1.5 million deaths each year. Many obstacles exist for low- and middle-income countries (LMIC) to progress towards accessible surgical care. The first challenge is delivering cost-effective surgical care despite financial constraints and political turmoil. Foreign aid was established to alleviate the financial burden and its contributions have been pivotal. However, based on the political climate in certain countries, funds are siphoned to government sectors other than health care. Moreover, the lack of infrastructure, equipment, and personnel in LMIC compound the issue. The other challenge is determining if surgery is as feasible and effective as non-surgical health interventions. Surgical care is crucial and this paper aims to assess the challenges that limit its stature in global health discussions. The paper will address the influence of financing, infrastructure, workforce, service delivery, and information management on surgical care, and the current resolutions, such as humanitarian aid missions.

scholarly journals Financial burden for tuberculosis patients in low- and middle-income countries: a systematic review

2014 ◽  
Vol 43 (6) ◽  
pp. 1763-1775 ◽  
Author(s):  
T. Tanimura ◽  
E. Jaramillo ◽  
D. Weil ◽  
M. Raviglione ◽  
K. Lonnroth
Keyword(s):  
Systematic Review ◽  
Financial Burden ◽  
Middle Income ◽  
Tuberculosis Patients ◽  
Middle Income Countries ◽  
Low And Middle Income

scholarly journals Access to medicines through health systems in low- and middle-income countries

2019 ◽  
Vol 34 (Supplement_3) ◽  
pp. iii1-iii3 ◽  
Author(s):  
Sachiko Ozawa ◽  
Raja Shankar ◽  
Christine Leopold ◽  
Samuel Orubu
Keyword(s):  
Health Systems ◽  
Universal Access ◽  
Financial Burden ◽  
Access To Medicines ◽  
Essential Medicines ◽  
Middle Income ◽  
Middle Income Countries ◽  
Systems Research ◽  
Access To Essential Medicines ◽  
Low And Middle Income

Abstract Nearly 2 billion people globally have no access to essential medicines. This means essential medicines are unavailable, unaffordable, inaccessible, unacceptable or of low quality for more than a quarter of the population worldwide. This supplement demonstrates the implications of poor medicine access and highlights recent innovations to improve access to essential medicines by presenting new research findings from low- and middle-income countries (LMICs). These studies answer key questions such as: Can performance-based financing improve availability of essential medicines? How affordable are cardiovascular treatments for children? Which countries’ legal frameworks promote universal access to medicines? How appropriately are people using medicines? Do poor-quality medicines impact equity? Answers to these questions are important as essential medicines are vital to the Sustainable Development Goals and are central to the goal of achieving Universal Health Coverage. Access to affordable, quality-assured essential medicines is crucial to reducing the financial burden of care, preventing greater pain and suffering, shortening the duration of illness, and averting needless disabilities and deaths worldwide. This supplement was organized by the Medicines in Health Systems Thematic Working Group of Health Systems Global, a membership organization dedicated to promoting health systems research and knowledge translation. The five studies in the supplement further our understanding by showcasing recent successes and challenges of improving access to quality-assured medicines through health systems in LMICs.

scholarly journals The household financial burden of non-communicable diseases in low- and middle-income countries: a systematic review

2021 ◽  
Vol 19 (1) ◽  
Author(s):  
Joseph Kazibwe ◽  
Phuong Bich Tran ◽  
Kristi Sidney Annerstedt
Keyword(s):  
Systematic Review ◽  
Social Protection ◽  
Financial Burden ◽  
Noncommunicable Diseases ◽  
Health Coverage ◽  
Qualitative Synthesis ◽  
Term Care ◽  
Middle Income ◽  
Middle Income Countries ◽  
Low And Middle Income

Abstract Background The chronic nature of noncommunicable diseases (NCD) and costs associated with long-term care can result in catastrophic health expenditure for the patient and their household pushing them deeper into poverty and entrenching inequality in society. As the full financial burden of NCDs is not known, the objective of this study was to explore existing evidence on the financial burden of NCDs in low- and middle-income countries (LMICs), specifically estimating the cost incurred by patients with NCDs and their households to inform the development of strategies to protect such households from catastrophic expenditure. Methods This systematic review followed the PRISMA guidelines, PROSPERO: CRD42019141088. Eligible studies published between 1st January 2000 to 7th May 2020 were systematically searched for in three databases: Medline, Embase and Web of Science. A two-step process, comprising of qualitative synthesis proceeded by quantitative (cost) synthesis, was followed. The mean costs are presented in 2018 USD. Findings 51 articles were included, out of which 41 were selected for the quantitative cost synthesis. Most of the studies were cross-sectional cost-of-illness studies, of which almost half focused on diabetes and/or conducted in South-East Asia. The average total costs per year to a patient/household in LMICs of COPD, CVD, cancers and diabetes were $7386.71, $6055.99, $3303.81, $1017.05, respectively. Conclusion This review highlighted major data and methodological gaps when collecting data on costs of NCDs to households along the cascade of care in LMICs. More empirical data on cost of specific NCDs are needed to identify the diseases and contexts where social protection interventions are needed most. More rigorous and standardised methods of data collection and costing for NCDs should be developed to enable comprehensive and comparable evidence of the economic and financial burden of NCDs to patients and households in LMICs. The available evidence on costs reveals a large financial burden imposed on patients and households in seeking and receiving NCD care and emphasizes the need for adequate and reliable social protection interventions to be implemented alongside Universal Health Coverage.

Some Conditions for Task Shifting in Low and Middle-Income Countries

2012 ◽  
Author(s):  
Joop de Jong ◽  
Mark Jordans ◽  
Ivan Komproe ◽  
Robert Macy ◽  
Aline & Herman Ndayisaba ◽  
...  
Keyword(s):  
Task Shifting ◽  
Middle Income ◽  
Middle Income Countries ◽  
Low And Middle Income
Sign in / Sign up

Export Citation Format

Share Document